SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP
- Recalling company
- SpecGx, LLC
- Product
- Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
- Reason
- Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Dec 16, 2025
- Reported
- Jan 14, 2026
- Distribution
- Nationwide
- Status
- Ongoing
- Quantity
- 74,544 bottles
- Lot / codes
- Lot: 0522J23493, expires: 03/2027.
- Company location
- Webster Groves, MO
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0255-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0255-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.